These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 6871494

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.
    Eichler I, Joris L, Hsu YP, Van Wye J, Bram R, Moss R.
    J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Rationale for development of immunotherapies that target mucoid Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Pier GB.
    Behring Inst Mitt; 1997 Feb; (98):350-60. PubMed ID: 9382760
    [Abstract] [Full Text] [Related]

  • 5. Specificity of opsonic antibodies to enhance phagocytosis of Pseudomonas aeruginosa by human alveolar macrophages.
    Reynolds HY, Kazmierowski JA, Newball HH.
    J Clin Invest; 1975 Aug; 56(2):376-85. PubMed ID: 807599
    [Abstract] [Full Text] [Related]

  • 6. Altered antibody isotype in cystic fibrosis: possible role in opsonic deficiency.
    Moss RB, Hsu YP, Sullivan MM, Lewiston NJ.
    Pediatr Res; 1986 May; 20(5):453-9. PubMed ID: 3714355
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Opsonization of mucoid and non-mucoid Pseudomonas aeruginosa by serum from patients with cystic fibrosis assessed by a chemiluminescence assay.
    LeBlanc CM, Bortolussi R, Issekutz AC, Gillespie T.
    Clin Invest Med; 1982 May; 5(2-3):125-8. PubMed ID: 6811181
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
    Kronborg G.
    APMIS Suppl; 1995 May; 50():1-30. PubMed ID: 7756034
    [Abstract] [Full Text] [Related]

  • 14. Bispecific antibodies overcome the opsonin-receptor mismatch of cystic fibrosis in vitro: restoration of neutrophil-mediated phagocytosis and killing of Pseudomonas aeruginosa.
    McCormick LL, Karulin AY, Schreiber JR, Greenspan NS.
    J Immunol; 1997 Apr 01; 158(7):3474-82. PubMed ID: 9120309
    [Abstract] [Full Text] [Related]

  • 15. Identification and rôle of immunoglobulins in respiratory secretions.
    Reynolds HY.
    Eur J Respir Dis Suppl; 1987 Apr 01; 153():103-16. PubMed ID: 3322854
    [Abstract] [Full Text] [Related]

  • 16. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O.
    APMIS Suppl; 2003 Apr 01; (116):1-47. PubMed ID: 14692154
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The role of IgG subclass antibodies in chronic infection: the case of cystic fibrosis.
    Moss RB.
    N Engl Reg Allergy Proc; 1988 Apr 01; 9(1):57-61. PubMed ID: 3362109
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A multicenter vaccine trial using the Pseudomonas aeruginosa flagella vaccine IMMUNO in patients with cystic fibrosis.
    Döring G, Dorner F.
    Behring Inst Mitt; 1997 Feb 01; (98):338-44. PubMed ID: 9382758
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.